Objectives Publicly available datasets dedicated to clinical speech deidentification tasks remain scarce due to privacy constraints and the complexity of speech-level annotation. To address this gap, we compiled the SREDH-AICup sensitive health information (SHI) speech corpus, a time-aligned clinical speech dataset annotated across 38 SHI categories. Methods Two publicly available English medical-domain datasets were adapted to support speech-level de-identification, including script reformulation and controlled re-recorded by 25 participants. Additional Mandarin Chinese clinical-style materials were incorporated to extend linguistic coverage. All audio data were annotated with million-level, time-aligned SHI spans using Label Studio. Inter-annotator agreement was evaluated using Cohen's kappa, following iterative calibration rounds. The resulting corpus supports both automatic speech recognition (ASR) and speech-level recognition of SHIs. Results The final dataset comprises 20 hours of annotated audio, divided into training (10 hours, 1,539 files), validation (5 hours, 775 files), and test (5 hours, 710 files) subsets, totalling 7,830 SHI entities. The language distribution reflects the composition of the selected source materials, with 19.36 hours of English and 0.89 hours of Mandarin Chinese speech. Discussion The corpus exhibits a long-tail distribution consistent with clinical documentation patterns and highlights the limited availability of Chinese medical speech resources. These characteristics underscore both the realism of the dataset and structural challenges associated with multilingual speech de-identification. Conclusion The SREDH-AICup SHI speech corpus provides a clinically grounded, time-aligned speech dataset supporting automated medical speech de-identification research and facilitating future development of multilingual speech-based privacy protection systems.

The authors have declared no competing interest.

This research was supported by Ministry of Education, ASUSTeK Computer Inc and the National Science and Technology Council under the grant number NSTC 114-2637-8-992-007-.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Development of this corpus was approved by the UNSW Sydney Human Research Ethics Committee (Approval No. HC17749).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes